| Literature DB >> 31850067 |
Sarah-Anne David1, Anaïs Vitorino Carvalho1, Coralie Gimonnet1, Aurélien Brionne1, Christelle Hennequet-Antier1, Benoît Piégu2, Sabine Crochet1, Nathalie Couroussé1, Thierry Bordeau1, Yves Bigot2, Anne Collin1, Vincent Coustham1.
Abstract
Changes in gene activity through epigenetic alterations induced by early environmental challenges during embryogenesis are known to impact the phenotype, health, and disease risk of animals. Learning how environmental cues translate into persisting epigenetic memory may open new doors to improve robustness and resilience of developing animals. It has previously been shown that the heat tolerance of male broiler chickens was improved by cyclically elevating egg incubation temperature. The embryonic thermal manipulation enhanced gene expression response in muscle (P. major) when animals were heat challenged at slaughter age, 35 days post-hatch. However, the molecular mechanisms underlying this phenomenon remain unknown. Here, we investigated the genome-wide distribution, in hypothalamus and muscle tissues, of two histone post-translational modifications, H3K4me3 and H3K27me3, known to contribute to environmental memory in eukaryotes. We found 785 H3K4me3 and 148 H3K27me3 differential peaks in the hypothalamus, encompassing genes involved in neurodevelopmental, metabolic, and gene regulation functions. Interestingly, few differences were identified in the muscle tissue for which differential gene expression was previously described. These results demonstrate that the response to embryonic thermal manipulation (TM) in chicken is mediated, at least in part, by epigenetic changes in the hypothalamus that may contribute to the later-life thermal acclimation.Entities:
Keywords: chicken; epigenetic; histone post-translational modification; reprogramming; thermal manipulation
Year: 2019 PMID: 31850067 PMCID: PMC6889634 DOI: 10.3389/fgene.2019.01207
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Summary of ChIP-seq results.Three biological replicates were sequenced per tissue and mark.
| Hypothalamus | Muscle P. major | |||
|---|---|---|---|---|
|
|
|
|
| |
| Analyzed peaks | 30597 | 23098 | 75943 | 26562 |
| Number of DP | 785 | 148 | 45 | 20 |
| % DP | 2.57 | 0.64 | 0.06 | 0.08 |
| Number of DP up | 147 | 37 | 7 | 4 |
| Number of DP down | 638 | 111 | 38 | 16 |
| Genes containing DP | 975 | 69 | 44 | 17 |
Reads were mapped against the chicken genome Galgal5, and peaks were detected using PePr for H3K4me3 and epic for H3K27me3. DP, Differential Peaks. Comparisons (DP up, DP down) were calculated as TM vs. control.
Figure 1Characteristics of differential peaks. (A) Percentage of ChIP-seq H3K4me3 differential peaks across genomic features in hypothalamus relative to all differential peaks, obtained using GenomeFeatures. Promoter and downstream regions were defined upstream of Transcription Start and End Sites (TSS and TES, respectively), respectively. (B) Barplot showing the ratio for each feature between the percentage of differential peaks (DP) per feature relative to all DP and the percentage of all peaks per feature vs. all peaks for H3K4me3 in hypothalamus. The color legend is the same as in . (C) Venn diagram showing the number of genes containing a DP that are specific or common for H3K4me3 (K4) and H3K27me3 (K27) marks in hypothalamus (HT) and muscle (M) tissues. (D) Box plot of H3K4me3 relative enrichment to input at CRY2, CDKL5, OCLN, and RGS4 loci in Control (blue) and TM (red) replicates. Box boundaries represent the first and third quartiles. The median is indicated by the bold horizontal line dividing the interquartile range. Upper and lower ticks indicate the 10th and 90th percentiles. Corresponding p-values are indicated at the top of each graph
Figure 2Functional analysis of hypothalamus and muscle genes bearing H3K4me3 and H3K27me3 differential peaks.The clustering heatmap plot of functional sets of gene ontology (GO) terms was obtained using ViSEAGO. From left to right are shown the major processes, the conditions defining the clusters (histone marks, tissues) defining the clusters, the cluster number, a heat map with the number of GO terms in each set and a dendrogram based on BMA semantic similarity distance and Ward’s clustering criterion.
Description of gene ontology (GO) clusters. For each cluster, the number of GO terms and the common ancestor term are shown
| Cluster | GO Terms (total: 154) | Common ancestor term |
|---|---|---|
| 1 | 10 | Cellular metabolic process |
| 2 | 9 | Regulation of metabolic process |
| 3 | 5 | Regulation of macromolecule metabolic process |
| 4 | 4 | Regulation of macromolecule biosynthetic process |
| 5 | 4 | Regulation of nucleobase-containing compound metabolic process |
| 6 | 9 | Regulation of RNA biosynthetic process |
| 7 | 6 | Organic substance metabolic process |
| 8 | 4 | Nucleobase-containing compound metabolic process |
| 9 | 7 | Cellular biosynthetic process |
| 10 | 4 | Neuron projection morphogenesis |
| 11 | 6 | Anatomical structure morphogenesis |
| 12 | 7 | Gliogenesis |
| 13 | 7 | Cellular developmental process |
| 14 | 6 | System development |
| 15 | 2 | Cerebral cortex cell migration |
| 16 | 4 | Ensheathment of neurons |
| 17 | 9 | Multicellular organismal process |
| 18 | 2 | Positive regulation of muscle hypertrophy |
| 19 | 5 | Negative regulation of biological process |
| 20 | 6 | Microtubule cytosekeleton organization |
| 21 | 10 | Cellular process |
| 22 | 6 | Process |
| 23 | 11 | Biological regulation |
| 24 | 5 | Metal ion transport |
| 25 | 3 | Cytokine secretion |
| 26 | 3 | Protein localization to cell cortex |
List of the canonical pathways identified by Ingenuity Pathway Analysis. The 25 significant pathways, with p-value < 0.05, are listed. The number and name of molecules participating in each pathway are shown in the “n =“ column
| Ingenuity Canonical Pathways | -log(p-value) |
| Molecules |
|---|---|---|---|
| AMPK Signaling | 3.81 | 21 | CHRNA5, ATF2, PPM1B, CAB39, PRKAR2B, PIK3CB, SMARCC1, FOXO6, RAB9B, RAB3A, PPARGC1A, CCND1, SMARCD3, PPP2R5D, CHRNB2, PRKAR1B, PPP2R2B, ELAVL1, PHF10, MAPK11, CHRM4 |
| RAN Signaling | 3.57 | 5 | CSE1L, KPNA4, KPNA6, RAN, RANBP1 |
| Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency | 2.79 | 7 | RARA, JARID2, BMI1, NR5A2, WWP2, CCNF, KDM5B |
| Geranylgeranyldiphosphate Biosynthesis | 2.69 | 2 | FDPS, GGPS1 |
| Calcium Signaling | 2.68 | 17 | CHRNA5, ATF2, NFATC2, PRKAR2B, CAMK2D, MICU1, TRPC3, CACNA1B, ATP2B1, PPP3CA, ATP2B2, MCU, CHRNB2, PRKAR1B, CACNA2D2, TPM1, RYR2 |
| CDK5 Signaling | 2.47 | 11 | PPP1R14C, KRAS, PRKAR2B, ADCY7, ITGB1, PPP2R5D, PRKAR1B, PPP2R2B, MAPK11, GNAL, MAPK6 |
| Trans, Trans-farnesyl Diphosphate Biosynthesis | 2.22 | 2 | FDPS, GGPS1 |
| BMP Signaling Pathway | 1.83 | 8 | KRAS, ATF2, PRKAR2B, PITX2, TLX2, PRKAR1B, MAPK11, SMURF1 |
| Netrin Signaling | 1.81 | 7 | NFATC2, PRKAR2B, PRKAR1B, CACNA1B, PPP3CA, CACNA2D2, RYR2 |
| GP6 Signaling Pathway | 1.71 | 10 | SCHIP1, COL4A6, LAMC3, PRKD3, KLF12, COL4A5, COL24A1, COL25A1, PIK3CB, PTK2 |
| Cardiac Beta-Adrenergic Signaling | 1.65 | 11 | PPP1R14C, PDE4A, PRKAR2B, ADCY7, PDE4D, PPP2R5D, PRKAR1B, PPP2R2B, AKAP1, PDE10A, RYR2 |
| Opioid Signaling Pathway | 1.62 | 17 | KRAS, ATF2, PRKAR2B, PRKD3, ADCY7, CLTC, CAMK2D, CACNA1B, PPP3CA, GNAL, RGS3, MAPK6, PRKAR1B, CACNA2D2, RGS4, GRK6, RYR2 |
| Sonic Hedgehog Signaling | 1.61 | 4 | GLIS2, PRKAR2B, PRKAR1B, HHIP |
| Corticotropin Releasing Hormone Signaling | 1.6 | 11 | ATF2, GUCY1A2, PRKAR2B, PRKD3, UCN, ADCY7, PRKAR1B, CACNA1B, MAPK11, CACNA2D2, CRHR2 |
| Synaptic Long Term Potentiation | 1.59 | 9 | PPP1R14C, KRAS, GRM2, ATF2, PRKAR2B, PRKD3, CAMK2D, PRKAR1B, PLCL2, PPP3CA |
| Dopamine-DARPP32 Feedback in cAMP Signaling | 1.58 | 12 | PPP1R14C, ATF2, GUCY1A2, PRKAR2B, PRKD3, ADCY7, PPP2R5D, PRKAR1B, PPP2R2B, PLCL2, PPP3CA, KCNJ10 |
| cAMP-Mediated Signaling | 1.55 | 16 | GRM2, ATF2, PDE4A, CNGA4, PRKAR2B, ADCY7, CAMK2D, PPP3CA, GNAL, PDE10A, PDE4D, PRKAR1B, CHRM4, RGS4, AKAP1, DUSP4 |
| RAR Activation | 1.52 | 13 | RARA, PRKAR2B, PRKD3, ADCY7, PIK3CB, SMARCC1, ALDH1A2, PPARGC1A, SMARCD3, PRKAR1B, PHF10, MAPK11, SRA1 |
| Protein Kinase A Signaling | 1.49 | 21 | ATF2, TCF3, PDE4A, NFATC2, CNGA4, PRKAR2B, PRKD3, ADCY7, CAMK2D, PPP3CA, PTK2, PDE10A, ANAPC10, PPP1R14C, PTPRG, PDE4D, PRKAR1B, PLCL2, AKAP1, DUSP4, RYR2 |
| Sperm Motility | 1.48 | 9 | PDE4A, GUCY1A2, CNGA4, PRKAR2B, PRKD3, PDE4D, PRKAR1B, PLCL2, PTK2 |
| Regulation of Cellular Mechanics by Calpain Protease | 1.46 | 6 | KRAS, CNGA4, CCND1, ITGB1, TLN2, PTK2 |
| Synaptic Long Term Depression | 1.44 | 12 | IGF1R, KRAS, GRM2, GUCY1A2, PRKD3, PPP2R5D, PPP2R2B, PLCL2, CACNA1B, CACNA2D2, GNAL, RYR2 |
| ERK/MAPK Signaling | 1.41 | 13 | KRAS, ATF2, PRKAR2B, TLN2, PIK3CB, PTK2, HSPB2, PPP1R14C, ITGB1, PPP2R5D, PRKAR1B, PPP2R2B, DUSP4 |
| Renin-Angiotensin Signaling | 1.4 | 10 | KRAS, ATF2, PRKAR2B, PRKD3, ADCY7, SHC2, PRKAR1B, MAPK11, PIK3CB, PTK2 |
| Mitotic Roles of Polo-Like Kinase | 1.32 | 5 | STAG2, PPP2R5D, PPP2R2B, SMC3, ANAPC10 |